NexCAR 19, A CAR-T Cell Therapy Drug Developed By ImmunoACT Approved By CDSCO | CNBC TV18

Indian drug regulator CDSCO has approved NexCAR 19, a cancer therapy drug developed by ImmunoACT. Co's Founder, CEO & Chairman Rahul Purwar tells Ekta Batra, Sonia Shenoy & Mangalam Maloo that aim is to scale current capacity by 6x to 3,000 patients next year vs 500 now
#lauruslab #immunoact #drugregulator #cancertherapy #cnbctv18 #businessnews #businessnewstoday #businessnewsinenglish
Read web story: www.cnbctv18.co...
🔴CNBC TV18 LIVE TV: th-cam.com/users/li...
SUBSCRIBE to our Channel: bit.ly/3nvEcxf
---------------------------------------------------------------------------------------------------------------------
👑 Check Out Top CNBC TV18 Playlist Videos:
🔹CNBC TV18 Digital Podcast: • I Did It My Way - CNBC...
🔹CNBC TV18 Classic Interviews: • CNBC-TV18 Classics
🔹CNBC TV18 Digital: • CNBC-TV18 Digital Videos
🔹CNBC TV18 Weekend Special: • CNBC-TV18 Weekend Special
🔹CNBC TV18 Next-Gen: • CNBCTV18 Next-Gen
🔹Overdrive Show: • OVERDRIVE || CNBC TV18
🔹CNBC TV18 Newsreels: • CNBC-TV18 Newsreel
🔹Young Turks: • YOUNG TURKS - The Entr...
🔹Starup Streets: • Startup Street
------------------------------------------------------------------------------------
You can also connect with CNBC-TV18 News Online
Catch the latest news: bit.ly/2YbpXBM
Follow CNBC-TV18 round the clock: www.cnbctv18.c...
Stay updated with all the market action in real time: www.cnbctv18.c...
You can also stay updated with all the latest news on-the-go with CNBC-TV18 Minis: www.cnbctv18.c...
Like us on Facebook: / cnbctv18india
Follow us on Twitter: / cnbctv18news
Follow us on Instagram: / cnbctv18india
Catch us on: Linkedin: / cnbc-tv18
n18oc_business
About CNBC-TV18: India's leading business news channel, CNBC-TV18 offers the most comprehensive coverage of businesses, the economy and the financial markets. Catch all your favourite shows, exclusive videos, big-ticket interviews and more here.

[@luciferkahn9809]

I would like to take car t cell theraphy for my 8years old kid,B All leukemia relapsed but i cant afford it.